SEI Investments
TRVI icon

SEI Investments’s Trevi Therapeutics TRVI Stock Holding History

SEI Investments’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
68,484
-9,738
-12% -$142K ﹤0.01% 2177
2026
Q1 		$933K Sell
78,222
-69,719
-47% -$781K ﹤0.01% 2391
2025
Q4 		$1.85M Buy
147,941
+62,143
+72% +$718K ﹤0.01% 1897
2025
Q3 		$785K Buy
+85,798
New +$643K ﹤0.01% 2067

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

SEI Investments's TRVI Position: Q2 2026 in Review

SEI Investments reduced its Trevi Therapeutics (TRVI) stake by 12% in Q2 2026, selling an estimated $142K and leaving 68,484 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

SEI Investments first reported a position in TRVI in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.85M in Q4 2025. 217 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • SEI Investments held 68,484 shares of Trevi Therapeutics worth $1.28M as of Q2 2026.
  • SEI Investments sold 9,738 Trevi Therapeutics shares in Q2 2026, an estimated $142K.
  • Trevi Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2177 holding.
  • SEI Investments first reported a position in Trevi Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • SEI Investments's Trevi Therapeutics position peaked at $1.85M in Q4 2025.
  • 217 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.